Aridol Kit — Competitive Intelligence Brief

Aridol Kit (Mannitol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic diuretic.

marketed Osmotic diuretic Glomerular filtrate osmolarity; tubular reabsorption of water Small molecule

Target snapshot

Aridol Kit (Mannitol) — Baxter. Osmotic diuretic that elevates glomerular filtrate osmolarity to inhibit tubular water reabsorption.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Aridol Kit TARGET	Mannitol	Baxter	marketed	Osmotic diuretic	Glomerular filtrate osmolarity; tubular reabsorption of water	1964-01-01
Aridol Kit	Mannitol	Baxter	marketed	Osmotic diuretic	Glomerular filtrate osmolarity; tubular reabsorption of water	1964-01-01
Aridol Kit	Mannitol	Baxter	marketed	Osmotic diuretic	Glomerular filtrate osmolarity; tubular reabsorption of water	1964-01-01
Mannitol	Mannitol	Baxter	marketed	Osmotic diuretic	Glomerular filtrate osmolarity; intracellular water movement	1964-01-01
Aridol Kit	MANNITOL	Baxter	marketed	Osmotic Diuretic [EPC]	sodium channels	1964-01-01
Mannitol 15%	Mannitol	Pfizer Inc.	marketed	Osmotic diuretic	Glomerular filtrate osmolarity; intracellular water movement
i.v. mannitol	i.v. mannitol	University Hospital, Saarland	marketed	Osmotic diuretic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic diuretic class)

1. Baxter · 4 drugs in this class
2. Centre Hospitalier Universitaire de Besancon · 1 drug in this class
3. Pfizer Inc. · 1 drug in this class
4. Thiogenesis Therapeutics, Inc. · 1 drug in this class
5. University Hospital, Grenoble · 1 drug in this class
6. University Hospital, Saarland · 1 drug in this class
7. Ain Shams University · 1 drug in this class
8. University of Aarhus · 1 drug in this class